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Introduction
One of the most common pathologies diagnosed in
patients presenting with abdominal pain coming to the
emergency room (ER) is acute pancreatitis (AP), which is a
major surgical challenge1 with the most common
triggering factor being gall stones.2 It is the inflammation
of the pancreas in which there is sudden activation of
pancreatic enzymes which self-digest and self-destruct the
pancreas itself. It is self-limiting in majority of cases, and
requires only symptomatic treatment, but severe disease is
present in 20-30% cases that can progress to systemic
inflammation and cause life-threatening necrosis of the
pancreas, multi-organ failure and can potentially lead to
death.2,3 A clinically-based classification system, the Atlanta
Classification, is widely used and accepted universally.4
Quick, accurate and early evidence-based risk stratification
of patients allows early initiation of intensive care therapy
for patients with severe acute pancreatitis (SAP) to prevent
adverse outcomes, like severe disease and mortality.5
Therefore, a tool that can stratify risk reliably in predicting
severity and prognoses of AP is of great importance when
it comes to managing AP patients.2
Accuracy, simplicity, promptness and precision are the
characteristics of an ideal scoring system and one which
can have reproducible description of the severity of
disease. There are a variety of systemic scores available to
evaluate and predict the severity and mortality in AP
patients. Ranson score, Acute Physiology and Chronic
Health Evaluation-II (APACHE II) and Computed
Tomography Severity Index (CTSI) are among the common
scoring systems used.6 Complex scoring systems, like
APACHE II, are suited well for the purpose of research, but
a more simplified scoring system, such as the Bedside Index
for Severity in AP (BISAP) is required to help physicians in
their routine clinical practices, predicting patient’s
adversities in a timely fashion.7 However, all scoring
systems have their own advantages and limitations. For
example, one of the limitations of the Ranson criteria is
missing the early therapeutic window as the score is not
completed till 48 hours of presentation of an AP patient.3
APACHE II has its complexity as a major drawback and
limitation, but has the advantage of allowing
determination and prediction of disease severity on the
very day of hospital admission.7 CTSI cannot reflect the
inflammatory and systemic response of patients, as its
calculation is based on computed tomography (CT) scan
findings of some local complications.6
The BISAP has been recently applied as a simple and
accurate method in predicting AP severity, with studies
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demonstrating its accuracy8 and mortality predictions
being similar to those of the other scoring systems,
including APACHE-IIand Ranson scores.6 BISAP was not only
proven to have high specificity, but also has a higher
negative predictive value (NOV) at scores >3.9 Incremental
rise in the value of BISAP score from 3 and above has shown
to correlate with an increased risk of pancreatic necrosis
leading to multi-organ failure (p<0.0001), and death as the
outcome.9
The current study was planned to determine the diagnostic
accuracy of BISAP in comparison with Ranson scores in
predicting mortalities and severities in AP patients in an ER
setting.
Patients and Methods
The cross-sectional study was conducted at the
Department of Emergency Medicine, Aga Khan University
Hospital (AKUH), Karachi, from July 1, 2017, to January 1,
2018. Approval from the institutional ethics review
committee was taken, also exemption for consent was
accepted by the hospital ethical review committee as this
study was cross sectional and did not require any
interventions. The sample size was calculated by assuming
sensitivity 71.5%, specificity 99.1% and prevalence 31.25%.8
The sample was raised using consecutive non-probability
sampling technique.
Those included were patients aged 16-75 years presenting
to the ER with epigastric pain who were found to have AP
on the basis of amylase or lipase level thrice the normal
value. Those excluded were patients with chronic kidney
disease (CKD), tumour lysis syndrome, chronic liver disease
(CLD), patients referred from other hospitals after 1-2 days
of Ap diagnosis and patients leaving against medical advice
(LAMA) <48 hours post-admission.
BISAP score was calculated as blood urea nitrogen (BUN)
>25mg/dL, abnormal mental status was taken as Glasgow
Coma Scale (GCS) score <15, patient’s age >60 years,
imaging study revealing effusion in pleural cavity, evidence
of systemic inflammatory response syndrome (SIRS) whose
manifestations include body temperature <36°C (96.8°F) or
>38°C (100.4°F), heart rate (HR) >90 beats per minute,
arterial partial pressure of carbon dioxide (PaO2) <32mmHg
or high respiratory rate tachypnoea >20 breaths per
minute, white blood cell (WBC) count <4x109 cells/L or
>12x109 cells/L, or the presence of >10% immature
neutrophils as band forms, with band forms >3% being
labelled as bandemia or a “left-shift”.8 When two or more
criteria were met, with or without evidence of infection, the
patient was labelled as having SIRS.8,9
Ranson score for non-gallstone pancreatitis score 1 was
given to all those having at admission age >55 years, WBC
count >16000 cells/mm3, blood glucose >200mg/dL, serum
aspartate aminotransferase (AST) >250IU/L, serum lactate
dehydrogenase (LDH) >350 IU/L; and at 48 hours serum
calcium <8.0mg/dL, haematocrit fall >10%, hypoxaemia
PaO2 <60mmHg, BUN having increased >5mg/dL after
intravenous (IV) fluid hydration, base deficit, or negative
base excess, >4mEq/L, and sequestration of fluids >6L.3,6
Ranson score for gallstone pancreatitis score 2 was given
to all those having at admission age >70 years, WBC count
>18000 cells/mm, blood glucose >220mg/dL, serum AST
>250IU/L, serum LDH >400IU/L; and at 48 hours, serum
calcium <8.0mg/dL, haematocrit fall >10%, hypoxaemia
PaO2 <60mmHg, BUN having increased by >2mg/dL after
IV fluid hydration, base deficit, or negative base excess,
>5mEq/L, and sequestration of fluids >4L. Scores 3 or more
were labelled as SAP.6,9
True positive (TP) level was set at score >3 for both BISAP
and Ranson, false positive (FP) at score >3, true negatives
(TN) at score <3, and false negative (FN) at score <3.
Sensitivity was taken as the ability to rule out mortality,
meaning TP + FN. Specificity was the ability to rule in
mortality, meaning TN + FP. Mortality was defined as death
occurring within hospital stay or within 28 days, and that
was labelled as positive.
Data was collected using the Emergency Severity Index-IV
(ESI-IV) as a triaging tool on the electronic database. Triage
system ESI-IV has five levels, from P1 to P5, with P1
requiring immediate intervention, P2 being in a high-risk
situation, while P3-P5 patients were categorised as per the
number of resources utilised in management. At the triage
counter, a standard set of vital signs were measured and
documented for all patients. All patients who came with
severe abdominal pain and were being managed in ER for
AP were enrolled using electronically-generated medical
record numbers. BISAP score was applied and calculated in
the ER, and the patients were followed in ward/intensive
care unit (ICU) where the Ranson score was calculated in
the following 48 hours. Both the scores were calculated to
predict severity and mortality for each patient.
Data was analysed using SPSS 20. Mean and standard
deviation (SD) of all quantitative variables, like age, systolic
blood pressure (SBP), HR, BISAP and Ranson scores, were
calculated. Also, shock index (SI) values were derived by
dividing HR with SBP.Frequencies and percentages were
calculated for gender, disposition, level of care and
mortality in Ranson and BISAP. Tables (2 x 2) were used to
calculate specificity, sensitivity, diagnostic accuracy (DA),
NPVs and positive predictive values (PPVs) for BISAP and
Ranson scores while keeping Ranson score as the gold
standard. Effect-modifiers, like age, gender, episode of
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pancreatitis, shock index, disposition of patient and level
of care, was dealt with through stratification and 2 x 2
tables to calculate specificity, sensitivity, NPV, PPV and DA
for BISAP and Ranson scores.
Results
Of the 136 patients, 88(64.7%) were males and 48(35.3%)
were females. The overall mean age was 42.04±16.42 years
(16-75 years) (Table 1), On the basis of BISAP and Ranson
scores, mild AP (MAP) and moderate AP (ModAP) were
diagnosed in 123(90.4%) and 119(87.5%) patients, while
SAP was diagnosed in 13(9.6%) and 17(12.5%) patients
respectively (Table 2). 
TP, FP, FN and TN values of the two scores were worked out
(Table 3). BISAP had specificity 94.62% compared to 91.54%
for Ranson score; sensitivity 100% vs 100%; NPV 100% vs
100%; PPV 46.15% vs 35.29%; and DA 94.85% vs 91.91%
(Table 4).
Discussion
AP can present in varying degrees, from a mild, self-limiting
disease to a severe and potentially life-threatening
condition. AP is a common surgical condition that is seen
worldwide associated with morbidity/mortality, and
adding to the burden on healthcare systems10 with several
studies reporting an increase in the incidence of disease
annually.11 As Ranson score is most commonly used for the
identification of AP severity and mortality in the current
setting, the current study used BISAP score for predicting
the same severity in the local population because of its
early identification of AP severity and mortality as well as
due to its cost effectiveness.
In the current study there were 136 AP patients, with a male
preponderance (64.7%). A similar study also reported high
prevalence among males (63.35%).2 Other studies12,13
reported the high prevalence of AP in females (59.1% and
66%). Difference in age was observed in these studies due
to difference in age selection of patients in AP. One study
reported male preponderance with mean age similar to
that in the current study.14 Like the current study, the other
study also showed that young adults were the most
affected.14
In the current study, mean BISAP score was 0.58±1.05 (0-5)
and mean Ranson score was 1.50±1.32 (0-9). One study
reported higher average of BISAP (1.0±0.8) and Ranson
(2.7±1.4) scores.2 Literature shows a cut-off value for ranson
score of ≥3 for SAP.15 On that basis, BISAP and Ranson score
diagnosed MAP and ModAP in 123(90.4%) and 119(87.5)
patients and SAP in 13(9.6%) and 17(12.5%) patients
respectively. Similar results were reported earlier2 while
contrasting results have also been found.13
In the current study, 6(4.4%) patients died in hospital and
all these patients were suffering from SAP. A. study reported
3(1.9%) deaths; 2 died due to SAP and 1 due to MAP.2
Another study reported high prevalence of AP mortality
(7.1%); mostly in SAP.12 High prevalence of mortality (>10%)
have been reported by a study.14
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Table-1: Descriptive statistics.
Variable n Minimum Maximum Mean±SD
Age (Years) 136 16 75 42.04±16.42
Gender
Male 88 16 73 40.88±16.06
Female 48 17 75 44.19±17.03
SD=Standard Deviation.
Table-2: Distribution of types of acute pancreatitis (AP) on the basis of bedside index
for severity in acute pancreatitis (BISAP) and Ranson scores (n=136). 
Types of AP BISAP Score Ranson Score
n (%) n (%)
MAP to ModAP 123 (90.4) 119 (87.5)
Severe AP 13 (9.6) 17 (12.5)
Total 136 (100) 136 (100)
MAP: Mild acute pancreatitis; ModAP: Moderate acute pancreatitis
Table-3: Sensitivity and specificity 2×2 table bedside index for severity in acute
pancreatitis (BISAP) and Ranson scores. 
GOLD STANDARD
Positive Negative
Positive True Positive (TP) False Positive (FP)










Table-4: Sensitivity, specificity, positive predictive value (PPV), negative predictive
value (NPV), and diagnostic accuracy (DA) of bedside index for severity in
acute pancreatitis (BISAP) and Ranson scores.
Variables Result





Diagnostic Accuracy 94.85% 91.91%
PPV: positive predictive value;  NPV: negative predictive value
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Conclusion
Both BISAP and Ranson scores were found to be very
reliable tools for the identification of AP patients at higher
risk of severity and mortality. BISAP and Ranson score had
the same sensitivity, but BISAP score had higher specificity
for predicting AP severity and mortality. Overall, BISAP had
an edge as Ranson score is calculated only after 48 hours.
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